The Global Regenerative Medicine Market by Therapy is expected to reach USD 38.70 Billion, at a CAGR of 23.6%.
The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Regenerative medicine market along with the estimates and forecasts of the revenue and market share analysis.
Don’t miss out on business opportunities in Regenerative Medicine Market by Therapy.
Regenerative Medicine Market by Therapy
The cell-based products are expected to dominate the global Regenerative Medicine market in 2016. Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
Orthopedic & Musculoskeletal Disorders, Dermatology, Cardiology, Central Nervous System Diseases will drive the growth of Regenerative Medicine Market by Therapy
Orthopedic & Musculoskeletal Disorders
The increasing prevalence of orthopedic diseases, rising aging population, increasing number of stem cell research projects and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders under both autologous and allogeneic cell therapies are the key drivers for the growth of this market.
According to WR Hambrecht & Co., a leading investment banking firm, the number of surgical procedures using orthobiologics and bone graft substitutes will continue to increase in the near future. Moreover, according to the U.S. Centers for Medicare and Medicaid Services, approximately 900,000 surgeries (which require bone regeneration) are performed annually in the U.S. Of these, spinal fusion (about 450,000 surgeries performed annually in the U.S.) was the most common surgery.
Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579
Central Nervous System Diseases
CNS diseases include a wide array of developmental, degenerative, and traumatic neurological conditions in the brain and spinal cord. Disorders associated with the central nervous system, such as Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), multiple sclerosis (MS), and stroke, are caused by a loss or dysfunction in neurons and glial cells in the brain or spinal cord.
Major Key players in the Regenerative Medicine:
Key players in the Regenerative medicine market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).
Read More in Detailed ( Regenerative Medicine Market )@
https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html
